Durata Therapeutics, Inc. — Net Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/e4ff3568-36e5-4821-bd2c-af008f3995f2/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2014 | $-207.3M | 2009-11-07 – 2014-06-30 | evidence 0001193125-14-299472 |
| FY 2013 | $-189.4M | 2009-11-07 – 2014-03-31 | evidence 0001193125-14-188738 |
| FY 2012 | $-123.1M | 2009-11-05 – 2013-03-31 | evidence 0001193125-13-209168 |
| FY 2011 | $-33.0M | 2011-01-01 – 2011-12-31 | evidence 0001193125-14-098872 |
| FY 2010 | $-11.0M | 2010-01-01 – 2010-12-31 | evidence 0001193125-14-098872 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).